Skip to main content
. 2017 Apr 10;8(32):52345–52356. doi: 10.18632/oncotarget.17017

Figure 7. Aldi-6 decreases cell viability of HNSCC cells.

Figure 7

(A) SCC4 and (B) PCI-13 cells were treated with Aldi-6 and/or cisplatin for two consecutive days. Then, the cells were analyzed on the fourth day. Cell viability was quantified using MTT assay. Results represent mean ± SEMs of 8–16 replicates. *p < 0.05 and **p < 0.0001 vs. control; #p < 0.005 vs. cisplatin only group; ## p < 0.05 vs. Aldi-6 only group (t-test).